Macro & Investment Insights

Stubborn Second Wave

  • 14 December 2020
  • 5min read

Key points

  • The Brexit noises are deafening but the key news flow remains the pandemic.
  • The current wave is relentless in the US.
  • Most of Europe is past the peak, but restrictive measures in Germany and France are toughened or prolonged. More policy support is needed, and recently the Euro area has been making progress, finally clearing the Recovery and Resilience Fund and getting a more than decent additional package from the ECB.

The news flow continues to be dominated by the post-Brexit talks. Even in the face of amped up rhetoric we continue to think a deal is the most plausible outcome, focusing as always on what we think should be the rational calculation by the British Prime Minister in the political realm: in case of “no deal” he would trade a few months of popularity with the most extreme members of his parliamentary group against a mountain of hurdles to electoral victory in four years.

Still, even in Europe the fate of the post-Brexit negotiations will only have a marginal impact on the economic trajectory for 2021 when compared to the pandemic. In the US the current wave remains relentless, making it more likely that the bulk of the impact may be seen in Q1 2021. This makes the continuation of fiscal support necessary to avoid more significant economic scarring before collective immunity is reached. The news flow on this remains inconclusive, even if we still think a compromise will be found between the two main parties. Meanwhile, Europe has cleared a major institutional hurdle on fiscal policy thanks to the deal on “rule of law” implementation struck with Hungary and Poland. The second wave’s damage continues to be concerning though. Most European countries seem to be past peak now, but it is taking more time than during the first wave to normalize sanitary conditions. Germany is about to implement a stricter lockdown from Wednesday onward. The economic impact – already significant in Q4 – is already spilling over Q1 2021.

In these conditions, the ECB had to offer more protection and we think the package announced last week will buy a lot of “peace and quiet” next year on the bond market. Market expectations had gone too far in the days ahead of the Governing Council meeting, but the central bank is still doing the maximum it can within its own constraints. The real question now is on the quantum of monetary support on offer once PEPP stops in March 2022 (at the earliest). Given the ECB’s inflation forecasts, which remain significantly below its target at the end of 2023, the logical conclusion is that the “ordinary” quantitative easing programme will be stepped up. This will be the toughest test on Christine Lagarde in our view. Of course, this sequencing would be jeopardized if inflation surprises on the upside. We take a hard look at this. While fading exogenous shocks should mechanically lift headline inflation next year, we expect little will come from the endogenous sources of price pressure – in particular the state of the labour market.

    Not for Retail distribution

    This document is intended exclusively for Professional, Institutional, Qualified or Wholesale Clients / Investors only, as defined by applicable local laws and regulation. Circulation must be restricted accordingly.

    This document is for informational purposes only and does not constitute investment research or financial analysis relating to transactions in financial instruments as per MIF Directive (2014/65/EU), nor does it constitute on the part of AXA Investment Managers or its affiliated companies an offer to buy or sell any investments, products or services, and should not be considered as solicitation or investment, legal or tax advice, a recommendation for an investment strategy or a personalized recommendation to buy or sell securities.

    It has been established on the basis of data, projections, forecasts, anticipations and hypothesis which are subjective. Its analysis and conclusions are the expression of an opinion, based on available data at a specific date.
    All information in this document is established on data made public by official providers of economic and market statistics. AXA Investment Managers disclaims any and all liability relating to a decision based on or for reliance on this document. All exhibits included in this document, unless stated otherwise, are as of the publication date of this document. Furthermore, due to the subjective nature of these opinions and analysis, these data, projections, forecasts, anticipations, hypothesis, etc. are not necessary used or followed by AXA IM’s portfolio management teams or its affiliates, who may act based on their own opinions. Any reproduction of this information, in whole or in part is, unless otherwise authorised by AXA IM, prohibited.

    Issued in the UK by AXA Investment Managers UK Limited, which is authorised and regulated by the Financial Conduct Authority in the UK. Registered in England and Wales, No: 01431068. Registered Office: 22 Bishopsgate, London, EC2N 4BQ. In other jurisdictions, this document is issued by AXA Investment Managers SA’s affiliates in those countries.